Benjamin J. Zeskind
Co-Founder, President, CEO & DirectorDr. Benjamin J. Zeskind, also known as Ben, Ph.D., MBA serves as the Co-Founder, President, Chief Executive Officer and Director of Immuneering Corporation since February 2008 and served as its Secretary. Dr. Zeskind served as Treasurer of Immuneering Corporation. Dr. Zeskind worked at Merck’s Global Marketing Division, IBM, Constant Contact, Bose and the US Army Natick Labs. His publications include: Maximizing the efficacy of angiogenesis inhibitors, Journal of Clinical Oncology, 2012; Lebrikizumab treatment in adults with asthma, New England Journal of Medicine, 2011 and Nucleic acid and protein mass mapping by live-cell deep-ultraviolet microscopy, Nature Methods, 2007. He received PhD at MIT in Biological Engineering and an MBA at Harvard Business School, Dr. Zeskind founded Immuneering to help pharma companies maximize the success of medicines through insights into the underlying biological mechanisms. His PhD research at MIT led to a first author publication in Nature Methods and two issued U.S. Patents. At Harvard Business School, he was recognized as a Baker Scholar, the highest award for distinction. Dr. Zeskind received his S.B. in electrical engineering and computer science from Massachusetts Institute of Technology.
Positions
- Company NameImmuneering CorporationStock CodeIMRXPositionCo-Founder, President, CEO & Director
